Workflow
上海盟科药业股份有限公司 简式权益变动报告书

Group 1 - The core point of the report is the equity change of Shanghai Mengke Pharmaceutical Co., Ltd. (stock code: 688373), where Best Idea International Limited has reduced its shareholding from 10.49% to 8.91% through a block trade on September 4, 2025 [1][10][24] - Best Idea International Limited held 68,752,718 shares before the reduction, which accounted for 10.49% of the total shares [9] - The reduction involved the transfer of 10,313,714 shares, representing 1.57% of the total share capital of the company [10][24] Group 2 - The purpose of the equity change is attributed to the funding needs of Best Idea International Limited, leading to the decision to reduce its holdings [7] - There are no plans or agreements for Best Idea International Limited to increase or decrease its shareholding in the next 12 months [8] - The equity change does not require approval from relevant authorities and does not impose any additional conditions [3] Group 3 - The transfer price for the shares was set at 6.57 yuan per share, which is 85% of the average trading price over the previous 20 trading days [26] - The transfer process involved 102 institutional investors, including private equity funds, public funds, and securities companies [26][27] - The transfer will not result in any change in the control of the company, as Best Idea International Limited is not a controlling shareholder [11][19]